- Home
- NNBR vs ATRA Comparison
NNBR vs ATRA Comparison
Compare NNBR & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNBR
- ATRA
- Stock Information
- Founded
- NNBR 1980
- ATRA 2012
- Country
- NNBR United States
- ATRA United States
- Employees
- NNBR N/A
- ATRA N/A
- Industry
- NNBR Industrial Machinery/Components
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NNBR Industrials
- ATRA Health Care
- Exchange
- NNBR Nasdaq
- ATRA Nasdaq
- Market Cap
- NNBR 90.4M
- ATRA 97.0M
- IPO Year
- NNBR 1994
- ATRA 2014
- Fundamental
- Price
- NNBR $1.52
- ATRA $12.04
- Analyst Decision
- NNBR
- ATRA Strong Buy
- Analyst Count
- NNBR 0
- ATRA 3
- Target Price
- NNBR N/A
- ATRA $21.00
- AVG Volume (30 Days)
- NNBR 132.6K
- ATRA 56.5K
- Earning Date
- NNBR 10-29-2025
- ATRA 11-12-2025
- Dividend Yield
- NNBR N/A
- ATRA N/A
- EPS Growth
- NNBR N/A
- ATRA N/A
- EPS
- NNBR N/A
- ATRA 0.56
- Revenue
- NNBR $424,005,000.00
- ATRA $188,667,000.00
- Revenue This Year
- NNBR N/A
- ATRA N/A
- Revenue Next Year
- NNBR $4.78
- ATRA N/A
- P/E Ratio
- NNBR N/A
- ATRA $21.68
- Revenue Growth
- NNBR N/A
- ATRA 202.41
- 52 Week Low
- NNBR $1.49
- ATRA $5.01
- 52 Week High
- NNBR $4.67
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- NNBR 32.63
- ATRA 42.83
- Support Level
- NNBR $1.51
- ATRA $10.53
- Resistance Level
- NNBR $1.76
- ATRA $12.89
- Average True Range (ATR)
- NNBR 0.12
- ATRA 1.26
- MACD
- NNBR -0.02
- ATRA -0.27
- Stochastic Oscillator
- NNBR 8.16
- ATRA 34.06
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).